Since its introduction, the FDA’s Process Analytical Technology (PAT) initiative has been gradually changing how pharmaceutical companies perceive the adoption of new technologies.
METTLER TOLEDO”S latest white paper discusses the drivers, goals and benefits of the PAT initiative.
It further highlights how innovative process analytical solutions with Intelligent Sensor Management (ISM®) can:
• Help to reduce production
cycle times
• Reduce the incidence of out
of specification conditions
• Ensure regulatory compliance
limits are met
Download the full version of
this white paper at:
For more information call 0116 234 5095 or email enquire.mtuk@mt.com
